Yahoo
NasdaqGS - Delayed Quote USD

Anavex Life Sciences Corp. (AVXL)

1.2600 +0.0600 (+5.00%)
At close: November 4 at 4:00:01 PM EST
1.2600 +0.0050 (+0.40%)
After hours: November 4 at 4:02:14 PM EST
Trade AVXL on Coinbase

News headlines

Updated 14m ago
Powered by Yahoo Scout

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as permanent president and chief executive officer after serving as interim CEO. The company is expanding blarcamesine development across Alzheimer’s disease, Rett syndrome, and Fragile X syndrome, while a recent board contest has shifted toward execution and governance oversight.

All SEC Filings

8-K : Corporate Changes & Voting Matters

November 3, 2026

8-K : Corporate Changes & Voting Matters

November 2, 2026

8-K : Corporate Changes & Voting Matters

October 20, 2026

8-K : Corporate Changes & Voting Matters

October 15, 2026

8-K : Corporate Changes & Voting Matters

September 28, 2026

DFAN14A : Proxy Statements

September 21, 2026

DFAN14A : Proxy Statements

September 18, 2026

DFAN14A : Proxy Statements

September 17, 2026

DEFA14A : Proxy Statements

September 15, 2026

DFAN14A : Proxy Statements

September 15, 2026

DEFA14A : Proxy Statements

September 14, 2026

DFAN14A : Proxy Statements

September 10, 2026

DFAN14A : Proxy Statements

September 10, 2026

DFAN14A : Proxy Statements

September 9, 2026

8-K : Corporate Changes & Voting Matters

September 9, 2026

DEFA14A : Proxy Statements

September 8, 2026

DFAN14A : Proxy Statements

September 4, 2026

DEFA14A : Proxy Statements

September 4, 2026

DFAN14A : Proxy Statements

September 3, 2026

DFAN14A : Proxy Statements

September 2, 2026

8-K : Corporate Changes & Voting Matters

September 2, 2026

DEFA14A : Proxy Statements

August 31, 2026

10-Q : Periodic Financial Reports

August 28, 2026

10-K/A : Periodic Financial Reports

August 28, 2026

10-Q : Periodic Financial Reports

August 28, 2026

10-Q/A : Periodic Financial Reports

August 28, 2026

PRRN14A : Proxy Statements

August 27, 2026

DEFC14A : Proxy Statements

August 27, 2026

8-K : Corporate Changes & Voting Matters

August 25, 2026

DEFA14A : Proxy Statements

August 24, 2026

8-K : Corporate Changes & Voting Matters

August 17, 2026

DEFA14A : Proxy Statements

August 17, 2026

DEFA14A : Proxy Statements

August 17, 2026

DEFA14A : Proxy Statements

August 11, 2026

DEFC14A : Proxy Statements

August 11, 2026

8-K : Corporate Changes & Voting Matters

August 11, 2026

NT 10-Q : Periodic Financial Reports

August 10, 2026

8-K : Corporate Changes & Voting Matters

August 3, 2026

PREC14A : Proxy Statements

July 31, 2026

8-K : Corporate Changes & Voting Matters

July 30, 2026

8-K : Corporate Changes & Voting Matters

July 20, 2026

8-K : Corporate Changes & Voting Matters

June 26, 2026

8-K : Corporate Changes & Voting Matters

May 22, 2026

8-K : Corporate Changes & Voting Matters

May 15, 2026

NT 10-Q : Periodic Financial Reports

May 11, 2026

8-K : Corporate Changes & Voting Matters

May 6, 2026

8-K : Corporate Changes & Voting Matters

March 25, 2026

8-K : Corporate Changes & Voting Matters

February 25, 2026

10-Q : Periodic Financial Reports

February 9, 2026

8-K : Corporate Changes & Voting Matters

February 9, 2026
Mobilize your Website
View Site in Mobile | Classic
Share by: